Trials / Completed
CompletedNCT00137878
TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer
A Phase II Randomized Trial Comparing TNFerade™ Biologic With Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- GenVec · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine if the addition of TNFerade™ to pre-operative chemoradiotherapy increases the number of pathologic complete responses when compared to pre-operative chemoradiotherapy alone as assessed following complete surgical resection of primary rectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TNFerade™ |
Timeline
- First posted
- 2005-08-30
- Last updated
- 2012-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00137878. Inclusion in this directory is not an endorsement.